BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6318064)

  • 21. Regulation of specific forms of cyclic nucleotide phosphodiesterases in cultured cells.
    Manganiello VC; Yamamoto T; Elks M; Lin MC; Vaughan M
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():291-301. PubMed ID: 6326529
    [No Abstract]   [Full Text] [Related]  

  • 22. Genetic analysis of cyclic nucleotide phosphodiesterases in Drosophila melanogaster.
    Kiger JA; Davis RL; Salz H; Fletcher T; Bowling M
    Adv Cyclic Nucleotide Res; 1981; 14():273-88. PubMed ID: 6269382
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cardiotropic effects of luliberin. Interaction with rat heart sarcolemmal membrane].
    Isachenkov VA; Bakalkin GIa; Kravtsov GM; Komissarova EN; Pokudin NI
    Biokhimiia; 1979 Mar; 44(3):387-93. PubMed ID: 223668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic analysis of cyclic nucleotide phosphodiesterases in S49 mouse lymphoma cells.
    Bourne HR; Brothers VM; Kaslow HR; Groppi V; Walker N; Steinberg F
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():185-94. PubMed ID: 6326523
    [No Abstract]   [Full Text] [Related]  

  • 25. Metabolic heterogeneity of the nephron.
    Kurokawa K
    Nihon Jinzo Gakkai Shi; 1981 Jul; 23(7):973-80. PubMed ID: 6275154
    [No Abstract]   [Full Text] [Related]  

  • 26. Hypertrophied right hearts get two for the price of one: can inhibiting phosphodiesterase type 5 also inhibit phosphodiesterase type 3?
    Kass DA
    Circulation; 2007 Jul; 116(3):233-5. PubMed ID: 17638937
    [No Abstract]   [Full Text] [Related]  

  • 27. An inhibitor of the toad bladder cyclic AMP system and theophylline-stimulated Na+ transport.
    Besley GT; Frith DA; Snart RS
    Steroids Lipids Res; 1974; 5(5-6):365-79. PubMed ID: 4376626
    [No Abstract]   [Full Text] [Related]  

  • 28. [Cyclic AMP-specific nucleotide phosphodiesterase from the insoluble fraction of the human brain].
    Kireeva NN; Bobruskin ID; Severin SE
    Biokhimiia; 1995 May; 60(5):694-708. PubMed ID: 7662796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implications of PDE4 structure on inhibitor selectivity across PDE families.
    Ke H
    Int J Impot Res; 2004 Jun; 16 Suppl 1():S24-7. PubMed ID: 15224132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Role of adenylate cyclase and the mechanism controlling platelet aggregation].
    Yoshida N; Aoki N
    Rinsho Byori; 1979; Suppl 40():47-53. PubMed ID: 233107
    [No Abstract]   [Full Text] [Related]  

  • 31. [The possible role of disruptions of the cyclic AMP system in the pathogenesis of thyrotoxic myopathies].
    Kazakov VM; Malakhovskiĭ VK; Khokhlov AP; Mikhaĭlov KP; Lozovskiĭ VT
    Vopr Med Khim; 1983; 29(6):69-73. PubMed ID: 6322441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclic AMP-mediated regulation of vascular smooth muscle cell cyclic AMP phosphodiesterase activity.
    Rose RJ; Liu H; Palmer D; Maurice DH
    Br J Pharmacol; 1997 Sep; 122(2):233-40. PubMed ID: 9313930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3.
    Feijge MA; Ansink K; Vanschoonbeek K; Heemskerk JW
    Biochem Pharmacol; 2004 Apr; 67(8):1559-67. PubMed ID: 15041473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Activity of Ca++-ATPase and enzymes of cycl AMP metabolism in the nervous tissue of rats at early stages of acute radiation sickness].
    Vasil'ev AN; Gavrileĭ VI; Grinchuk DV; Maĭdaniuk AV; Matyshevskaia OP
    Radiobiologiia; 1982; 22(6):815-7. PubMed ID: 6296914
    [No Abstract]   [Full Text] [Related]  

  • 36. Distinct profiles of phosphodiesterase isozymes in cultured cells derived from nonpigmented and pigmented ocular ciliary epithelium.
    Bode DC; Hamel LT; Wax MB
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1286-91. PubMed ID: 8263791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta-adrenergic receptor regulation of a cyclic AMP phosphodiesterase in C6 glioma cells.
    Schwartz JP; Onali P
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():195-203. PubMed ID: 6326524
    [No Abstract]   [Full Text] [Related]  

  • 38. [Bioluminescence and its analytic applications].
    Ricci C
    Quad Sclavo Diagn; 1983 Dec; 19(4):415-31. PubMed ID: 6146159
    [No Abstract]   [Full Text] [Related]  

  • 39. [Metabolic properties of Hürthle cell adenoma].
    Califano G; Abate S; Ferulano GP; Caputo G; Catapano R; Macchia V
    Minerva Med; 1980 Jun; 71(23):1657-60. PubMed ID: 6247676
    [No Abstract]   [Full Text] [Related]  

  • 40. Specific effects of n-3 fatty acids and 8-bromo-cGMP on the cyclic nucleotide phosphodiesterase activity in neonatal rat cardiac myocytes.
    Picq M; Dubois M; Grynberg A; Lagarde M; Prigent AF
    J Mol Cell Cardiol; 1996 Oct; 28(10):2151-61. PubMed ID: 8930810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.